[Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection]
- PMID: 15750679
- DOI: 10.1007/s00120-005-0785-9
[Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection]
Abstract
Locally recurrent renal cell carcinoma (RCC) is 0-10% after nephron-sparing surgery, 2.5-4% after thermoablative interventions and 2-3% after (radical) nephrectomy. Risk-factors are: sporadic or hereditary origin, tumor size, multifocality, histologic phenotype and incomplete resection. To date, there are no significant differences in the incidence of locally recurrent tumors independently of whether open or laparoscopic techniques were preferred. Caution still has to be taken with the use of alternative tools for minimally invasive tumor ablation.Finally, no statistically proven standard therapy exists that would clearly provide a superior outcome for patients with an isolated local recurrence. However, meta-analyses strongly support the performance of a resection of the recurrence as the primary working principal.
Similar articles
-
Open surgery for localized RCC.ScientificWorldJournal. 2007 Jan 22;7:742-52. doi: 10.1100/tsw.2007.142. ScientificWorldJournal. 2007. PMID: 17619756 Free PMC article. Review.
-
Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma.Scand J Surg. 2004;93(2):126-31. doi: 10.1177/145749690409300207. Scand J Surg. 2004. PMID: 15285564 Review.
-
[Nephron-sparing therapy for renal tumors].Aktuelle Urol. 2007 Mar;38(2):126-31; discussion 125. doi: 10.1055/s-2007-959198. Aktuelle Urol. 2007. PMID: 17390274 Review. German.
-
Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.J Urol. 2009 May;181(5):2044-51. doi: 10.1016/j.juro.2009.01.043. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286220
-
Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.J Endourol. 2010 Oct;24(10):1609-12. doi: 10.1089/end.2010.0051. J Endourol. 2010. PMID: 20629564
Cited by
-
[When is aftercare useful in renal cell cancer?].Urologe A. 2005 Sep;44(9):1018, 1020-3. doi: 10.1007/s00120-005-0880-y. Urologe A. 2005. PMID: 16047197 Review. German.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical